TP53 and cancer: The DDR, therefore, has been envisaged as an intrinsic anti-cancer barrier that needs to be disrupted (i.e., via inactivation of the ATM or p53) for cell transformation to proceed (Bartkova et al., 2005; Gorgoulis et al., 2005; Di Micco et al., 2006).